Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer - Tagawa, S T; Milowsky, M I; Morris, M (Clin Cancer Res, 2013)